FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) fourth-quarter results, based on a poll of 11
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released February 6.
===
Net Business Business Business
4th Quarter sales Oper. Income net income EPS
AVERAGE 8,470 2,509 1,816 1.36
Prev. Year 8,526 2,118 1,550 1.17
+/- in % -0.7 +18 +17 +17
MEDIAN 8,438 2,501 1,807 1.37
Maximum 8,745 2,711 1,925 1.46
Minimum 8,338 2,410 1,765 1.31
Amount (a) 11 11 9 11
Banca Sabadell 8,554 2,532 1,807 1.37
Bernstein 8,338 2,501 1,805 1.37
Deutsche Bank 8,405 2,518 1,811 1.37
Exane BNP Paribas 8,745 2,503 1,796 1.36
Helvea 8,466 2,500 1,781 1.35
Kepler Cheuvreux 8,379 2,455 -- 1.31
Morgan Stanley 8,632 2,454 1,765 1.33
UBS 8,438 2,475 1,814 1.37
Target price Rating DPS 2013
AVERAGE 83.07 positive 6 AVERAGE 2.80
Prev. Quarter 86.00 neutral 3 Prev. Year 2.77
+/- in % -3.4 negative 1 +/- in % +1.1
MEDIAN 84.60 MEDIAN 2.80
Maximum 90.00 Maximum 2.85
Minimum 75.00 Minimum 2.76
Amount 9 Amount 6
Banca Sabadell 84.60 Sell 2.77
Berenberg 86.00 Buy 2.76
Citigroup 76.00 Neutral 2.80
Credit Suisse 85.00 Neutral 2.80
Deutsche Bank 87.00 Buy 2.83
Exane BNP Paribas 83.00 Outperform 0.00
Helvea 81.00 Buy --
Kepler Cheuvreux 90.00 Buy 2.85
Morgan Stanley -- Overweight --
UBS 75.00 Neutral --
===
Year-earlier figures are as restated by the company.
(a) Including anonymous estimates from three more analysts.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires